Skip to main content
. 2020 Jan 13;13(1):dmm043281. doi: 10.1242/dmm.043281

Fig. 6.

Fig. 6.

Nonsense-mediated decay (NMD) and read-through analysis in McArdle myotubes. (A-C) PYGM mRNA levels in WT and McArdle mouse myotubes after 72 h treatment with different concentrations of amlexanox (AML) (A), Ataluren (ATL) (B) and G418 (C), respectively. (D-F) GP-M protein levels in WT and McArdle mouse myotubes after 72 h treatment with different concentrations of AML (D), ATL (E) and G418 (F), respectively. Black arrows mark the specific PYGM protein band (94 kDa); blue arrows mark unspecific protein bands.